FDA NDC Directory · JSON-LD · Markdown

ziprasidone mesylate

NDC 68083-340 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerGland Pharma Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA211908
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAMUSCULAR
Active ingredientsZIPRASIDONE MESYLATE (20 mg/mL)
Marketing started20191226
Package count1

External sources

Source: openFDA. Public-domain (CC0).